OTLKW
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
OTLKW
Delisted
OTLKW was delisted on the 16th of February, 2022.
7 hedge funds and large institutions have $132K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.83K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $50K | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $48K | – | – | – |
|
|
MWNA
3
Marshall Wace North America
New York
| $15K | – | – | – |
|
|
PC
4
PointState Capital
New York
| $12K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$1.83K | +16,637 | +84% |
|
|
MIM
6
Monashee Investment Management
Boston,
Massachusetts
| $3K | – | – | – |
|